Cardio Diagnostics Holdings, Inc. (CDIO) investor relations documents from the company's IR site: 1 presentation, 6 press releases; latest deck 2026-08-19. Read in-app with summaries. First-party data.
Company Update 2026: Cardio Diagnostics offers AI-driven multi-omics cardiovascular tests (Epi+Gen CHD™, PrecisionCHD™) for personalized prevention and diagnosis, targeting a $175B+ TAM.
| Published | Type | Document |
|---|---|---|
| 2026-08-19 | Presentation | Company Update 2026 |
| 2026-08-05 | Press release | PDF Version |
| Press release | Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 | |
| 2026-02-18 | Press release | PDF Version |
| 2026-02-17 | Press release | PDF Version |
| Press release | CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026 | |
| Press release | Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026 |
CDIO overview · CDIO earnings · CDIO financials · CDIO KPIs · CDIO documents · CDIO ownership · CDIO peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.